IRS
Next report

Nov 4 2026in 21 days

EPS estimate

($0.00)

Revenue estimate

$91M

ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Sep 3 2026—$1.57—$35M$129M+271.1%
May 6 2026—($0.28)—$35M$102M+192.0%
Feb 4 2026—$0.58—$60M$105M+75.6%
Nov 5 2025—$1.42—$68M$91M+32.9%
Sep 2 2025—$1.74—$74M$93M+25.9%
May 6 2025—$0.89—$54M$98M+82.4%
Feb 7 2025—$0.92—$46M$147M+220.9%
Nov 6 2024—($1.50)—$541M$122M-77.5%
Sep 3 2024—$1.26——$126M—
May 7 2024—$1.42—$47M$123M+160.6%
Feb 5 2024—$0.73—$30M$208M+594.4%
Nov 7 2023—$3.25—$31M$227M+636.5%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+27.53%
EPS-90.30%
FY2028
Rev+11.07%
EPS-17.10%
FY2029
Rev+28.16%
EPS+21.21%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2027EFY2028EFY2029E
Revenue Avg$634.32B$704.56B$902.97B
Low$634.32B$704.56B$902.97B
High$634.32B$704.56B$902.97B
EBITDA Avg$83.43B$79.67B$77.98B
Low$83.43B$79.67B$77.98B
High$83.43B$79.67B$77.98B
EBIT Avg$59.72B$59.23B$59.73B
Low$59.72B$59.23B$59.73B
High$59.72B$59.23B$59.73B
Net Income Avg$2.26B$1.87B$2.27B
Low$2.26B$1.87B$2.27B
High$2.26B$1.87B$2.27B
EPS Avg$289.77$240.21$291.17
Low$289.77$240.21$291.17
High$289.77$240.21$291.17
Analysts (Rev / EPS)1 / 11 / 11 / 1
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028Q3 2028
Revenue Avg$35.19B$72.10B$66.47B$66.47B$69.81B$81.91B$108.18B$103.87B
Low$35.19B$72.10B$66.47B$66.47B$69.81B$81.91B$108.18B$103.87B
High$35.19B$72.10B$66.47B$66.47B$69.81B$81.91B$108.18B$103.87B
EBITDA Avg————————
Low————————
High————————
EBIT Avg————————
Low————————
High————————
Net Income Avg————————
Low————————
High————————
EPS Avg————————
Low————————
High————————
Analysts (Rev / EPS)1 / —1 / —1 / —1 / —1 / —1 / —1 / —1 / —
AI Earnings SummaryQ4 2026
Checking for summary...

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.